MedTrace Logo

Screening for Lung Cancer in the HIV Patient

NCT01748136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-03-28

No results posted yet for this study

Summary

That computed tomography (CT) screening of HIV-seropositive heavy smokers will detect early stage lung cancer at significantly higher rates than what is currently being observed.

Conditions

  • Lung Cancer in the HIV Patient
  • HIV Infections
  • HIV Seropositivity
  • Lung Cancer

Interventions

DEVICE

CT Scan with Spirometry

During the screening and later during the five annual study visits the patients will be scheduled to undergo total of five CT scans. The first CT scan will take place at the beginning of the study and then each year for a period of five years.

Sponsors & Collaborators

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    lead OTHER

Principal Investigators

  • Malcolm Brock, MD · Johns Hopkins University

Eligibility

Min Age
26 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2011-09-30
Completion
2011-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01748136 on ClinicalTrials.gov